Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Jun;63(6):2445-51.
doi: 10.1128/JVI.63.6.2445-2451.1989.

Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus

Affiliations

Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus

R C Cheung et al. J Virol. 1989 Jun.

Abstract

In this article we report the first topological mapping of neutralizing epitopes of a hepadnavirus. Duck hepatitis B virus is the only hepadnavirus that can replicate and spread from cell to cell in tissue culture. As a result, it is possible to study hepadnaviral neutralization in vitro with this system. To accomplish this goal, we produced a library of monoclonal antibodies against duck hepatitis B virus and identified 12 neutralizing monoclonal antibodies by using an in vitro neutralization assay. The characteristics of six of the neutralizing monoclonal antibodies were further studied by epitope mapping. From the results of competitive binding studies, three distinct neutralizing epitopes were identified on the pre-S polypeptides and one was identified on the S polypeptide. Our findings suggest that antibodies to both the pre-S and S gene products of duck hepatitis B virus can neutralize viral infection in vitro. The pre-S gene product is at least as important as the S gene product in eliciting neutralizing antibodies.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Virol. 1987 May;61(5):1384-90 - PubMed
    1. Virology. 1986 Dec;155(2):434-51 - PubMed
    1. Hepatology. 1987 Jul-Aug;7(4):724-31 - PubMed
    1. Mol Immunol. 1987 Sep;24(9):975-80 - PubMed
    1. Bull World Health Organ. 1987;65(3):265-75 - PubMed

Publication types